TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10971235

Group type: EXPERIMENTAL
Intervention: 1 L of cafetière (French press) coffee daily
Number of subjects: 64

Group type: COMPARATOR
Intervention: No coffee
Number of subjects: 64
Study: 8971064

Group type: EXPERIMENTAL
Intervention: Selenium treatment (200 microg per day)
Number of subjects: 1312

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1312
Study: 1611965

Group type: EXPERIMENTAL
Intervention: Enalapril (10-20 mg daily)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Metoprolol (100-200 mg daily)
Number of subjects: 36
Study: 30661082

Group type: EXPERIMENTAL
Intervention: Dried blood spots (DBS)
Number of subjects: 50
Study: 28176599

Group type: EXPERIMENTAL
Intervention: Combined (oral + topical) tranexamic acid (TXA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Topical tranexamic acid (TXA)
Number of subjects: 100
Study: 27527817

Group type: EXPERIMENTAL
Intervention: Fast injection (2‐4mL/s)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Slow injection (5‐10mL/s)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fast injection
Number of subjects: 120

Group type: COMPARATOR
Intervention: Slow injection
Number of subjects: 120
Study: 25105547

Group type: EXPERIMENTAL
Intervention: Supervised exercise program (SEP) plus at home nonsupervised exercise therapy (non‐SET)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Usual supervised exercise program (SEP) according to a common cardiovascular program
Number of subjects: 117
Study: 22357106

Group type: EXPERIMENTAL
Intervention: PINCER intervention (pharmacist-led information technology intervention)
Number of subjects: 480942

Group type: COMPARATOR
Intervention: Control group (computer-generated simple feedback for at-risk patients)
Number of subjects: 480942
Study: 20402818

Group type: EXPERIMENTAL
Intervention: Azithromycin, ofloxacin, bismuth, and omeprazole
Number of subjects: 220

Group type: COMPARATOR
Intervention: Amoxicillin, clarithromycin, bismuth, and omeprazole
Number of subjects: 220
Study: 17854748

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 0
Study: 15791634

Group type: COMPARATOR
Intervention: Sarizotan (5-HT1A agonist) at 2 and 5 mg twice daily
Number of subjects: 18
Study: 11978899

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 300 mg/kg over 20 h
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 30
Study: 9856380

Group type: EXPERIMENTAL
Intervention: Balloon angioplasty
Number of subjects: 100

Group type: COMPARATOR
Intervention: Antihypertensive medication
Number of subjects: 100
Study: 7824707

Group type: EXPERIMENTAL
Intervention: MR imaging
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: TEE
Number of subjects: 41
Study: 2162281

Group type: EXPERIMENTAL
Intervention: Inspiratory flow rate of 50 l/min
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inspiratory flow rate of 150 l/min
Number of subjects: 11
Study: 374707

Group type: EXPERIMENTAL
Intervention: Cut toothbrush bristles (CP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Round ended toothbrush bristles (RP)
Number of subjects: 30
Study: 30610423

Group type: EXPERIMENTAL
Intervention: Ahmed glaucoma valve (AGV) implantation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Suprachoroidal silicone tube (SST) implantation
Number of subjects: 23
Study: 26149677

Group type: EXPERIMENTAL
Intervention: Meditation condition
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 63
Study: 26073411

Group type: EXPERIMENTAL
Intervention: Part D plan switching
Number of subjects: 185960

Group type: EXPERIMENTAL
Intervention: Factors affecting switching
Number of subjects: 185960
Study: 23584194

Group type: EXPERIMENTAL
Intervention: Seeking Safety (SS)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Women's Health Education
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Baseline abstinence
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Living with someone with an alcohol problem
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Recent interpersonal trauma at baseline and higher total of lifetime trauma exposures
Number of subjects: 288
Study: 21672347

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg bolus followed by 2 mg/kg/h infusion)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 64
Study: 19801246

Group type: EXPERIMENTAL
Intervention: K-files (group 1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: M-Two NiTi rotary instruments (group 2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ESI ultrasonic tips (group 3)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Thermafil
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vertically compacted warm gutta-percha
Number of subjects: 36

Group type: COMPARATOR
Intervention: Coronal third (control)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Middle third
Number of subjects: 36

Group type: COMPARATOR
Intervention: Apical third
Number of subjects: 36
Study: 17083585

Group type: EXPERIMENTAL
Intervention: Poly-L-lactic acid (PLLA) injections
Number of subjects: 0
Study: 15580192

Group type: EXPERIMENTAL
Intervention: 8 weeks of stationary cycling
Number of subjects: 25

Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 25
Study: 11423702

Group type: EXPERIMENTAL
Intervention: Mixture of 68 g olive and 12 g sunflower oil/day (MO; total 80 g)
Number of subjects: 28

Group type: COMPARATOR
Intervention: 80 g corn oil (CO)/day
Number of subjects: 28
Study: 9268794

Group type: EXPERIMENTAL
Intervention: Total knee arthroplasty (TKA) with various techniques (semiconstrained, with/without posterior cruciate ligament retention, resurfacing of the patella, cement fixation)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Age-matched control group (32 knees in 32 patients without TKA)
Number of subjects: 55
Study: 8329907

Group type: EXPERIMENTAL
Intervention: Local anesthesia given before surgery (group 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Local anesthesia given after surgery (group 2)
Number of subjects: 0
Study: 3333523

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg once daily
Number of subjects: 18

Group type: COMPARATOR
Intervention: Propranolol 160 mg slow release once daily
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 29724529

Group type: EXPERIMENTAL
Intervention: Fortified yogurt (FY) - 2 servings (2 x 250 g)/day
Number of subjects: 87

Group type: COMPARATOR
Intervention: Low-fat plain yogurt (PY) - control group
Number of subjects: 87
Study: 28480650

Group type: EXPERIMENTAL
Intervention: DEB + BMS
Number of subjects: 180

Group type: COMPARATOR
Intervention: ZES
Number of subjects: 180
Study: 26651471

Group type: EXPERIMENTAL
Intervention: Internet-based physical activity intervention
Number of subjects: 55

Group type: COMPARATOR
Intervention: Active control arm
Number of subjects: 55
Study: 24004498

Group type: EXPERIMENTAL
Intervention: Electronic alcohol screening and brief intervention (e‐SBI)
Number of subjects: 772

Group type: COMPARATOR
Intervention: Screening alone (control)
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: e‐SBI
Number of subjects: 772
Study: 20978709

Group type: EXPERIMENTAL
Intervention: Clopidogrel treatment (75 mg/day) with MEA assessment
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Clopidogrel treatment (75 mg/day) with LTA assessment
Number of subjects: 31
Study: 18316662

Group type: EXPERIMENTAL
Intervention: Baseline depressive symptoms measured with the Center for Epidemiological Studies Depression Scale
Number of subjects: 269

Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Baseline depressive symptoms
Number of subjects: 269
Study: 16974167

Group type: EXPERIMENTAL
Intervention: Clear liquid diet/magnesium citrate and bisacodyl prep
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Diet kit/magnesium citrate and bisacodyl prep
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Diet kit/polyethylene glycol electrolyte prep
Number of subjects: 114

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 114
Study: 14579086

Group type: EXPERIMENTAL
Intervention: Group I (AD)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Group II (MCI)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Left prefrontal, left frontal and left parietal areas
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Medial temporal and anterior lateral temporal cortex
Number of subjects: 42
Study: 10704616

Group type: EXPERIMENTAL
Intervention: LDL+VLDL oxidizability
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Glycemic control (HbA(1))
Number of subjects: 34

Group type: COMPARATOR
Intervention: Type-I diabetic patients
Number of subjects: 34
Study: 9347432

Group type: EXPERIMENTAL
Intervention: Isoflurane‐N2O‐opioid general anesthesia
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combined epidural‐general anesthesia
Number of subjects: 24

Group type: COMPARATOR
Intervention: All patients (combined analysis)
Number of subjects: 24
Study: 8477408

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 6
Study: 2943760

Group type: EXPERIMENTAL
Intervention: Topical 1% clindamycin phosphate applied twice daily for 8 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Vehicle applied twice daily for 8 weeks
Number of subjects: 32
Study: 31480553

Group type: EXPERIMENTAL
Intervention: Caffeine supplement (CAF; 6 mg∙kg‐1)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 15
Study: 27198532

Group type: EXPERIMENTAL
Intervention: FHH-based assessments provided to all adult household members
Number of subjects: 1401

Group type: COMPARATOR
Intervention: FHH-based assessments provided to one adult household member
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: New encouragement from parent-to-child
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: New encouragement from child-to-parent
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: Baseline encouragement for PA and HW
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: Baseline co-engagement in PA
Number of subjects: 1401
Study: 25677309

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 231
Study: 24090039

Group type: EXPERIMENTAL
Intervention: Bespoke online clinical skills training videos (TV)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Revision as usual (RAU)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups (TV and RAU)
Number of subjects: 22
Study: 22379770

Group type: EXPERIMENTAL
Intervention: Vacuum-assisted venous drainage technology (VAVD) during cardiopulmonary bypass (CPB) in MICS
Number of subjects: 70
Study: 19556801

Group type: EXPERIMENTAL
Intervention: Injections every month for 6 months, then every 3 months for a total of 15 months
Number of subjects: 112

Group type: COMPARATOR
Intervention: Injections every 3 months for 15 months
Number of subjects: 112
Study: 17595452

Group type: EXPERIMENTAL
Intervention: Vitamin E (2800 mg daily for 7 days)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 15493391

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3% mepivacaine
Number of subjects: 40
Study: 11158795

Group type: EXPERIMENTAL
Intervention: Viscocanalostomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 20
Study: 10099043

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate 50 mg intramuscularly weekly and 1,000 mg oral calcium carbonate daily (NDC group)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Calcium alone 1,000 mg oral calcium carbonate daily (CAL group)
Number of subjects: 21
Study: 7656846

Group type: EXPERIMENTAL
Intervention: Intracoronary bisoprolol (0.01 mg/kg body weight)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intravenous bisoprolol (2.5 mg)
Number of subjects: 14
Study: 2741219

Group type: EXPERIMENTAL
Intervention: 4-epiadriamycin and cyclophosphamide for 8 courses followed by 6 cycles of CMF and MPA until progression (Group A)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Adriamycin + cyclophosphamide alternated with CMF every two courses until 14 cycles completed (Group B)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: 4'-epiadriamycin + cyclophosphamide alternated with CMF for 14 courses (Group C)
Number of subjects: 250
Study: 237849

Group type: EXPERIMENTAL
Intervention: Bromazepam (5 mg t.d.s. for 3 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Diazepam (5 mg t.d.s. for 3 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bromazepam
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bromazepam and Diazepam
Number of subjects: 30
Study: 31886931

Group type: EXPERIMENTAL
Intervention: Met + Lifestyle
Number of subjects: 450

Group type: COMPARATOR
Intervention: Metformin (Met)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Met + Rosiglitazone (Rosi)
Number of subjects: 450
Study: 30935251

Group type: EXPERIMENTAL
Intervention: SCFW (water-based facial sunscreen)
Number of subjects: 0
Study: 28291977

Group type: EXPERIMENTAL
Intervention: Substance-dependent women (alcohol and opiate)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Opiate-dependent females
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Alcohol-dependent females
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 62
Study: 26678937

Group type: EXPERIMENTAL
Intervention: IV paracetamol
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 25402241

Group type: EXPERIMENTAL
Intervention: Modified glass ionomer resin sealant (Vitremer, 3M ESPE) with oral health education every three months + a single application of sealant
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Fluoride varnish (Duraphat, Colgate) with oral health education every three months + varnish biannually
Number of subjects: 268

Group type: COMPARATOR
Intervention: High risk controls (oral health education every three months)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Low risk controls (oral health education every three months)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: High risk with varnish (oral health education every three months + varnish biannually)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Low risk with varnish (oral health education every three months + varnish biannually)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: High risk with sealant (oral health education every three months + a single application of sealant)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Low risk with sealant (oral health education every three months + a single application of sealant)
Number of subjects: 268
Study: 21840466

Group type: EXPERIMENTAL
Intervention: High-fat diet (40% of energy as fat)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low-fat diet (20% of energy)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low-fat diet + n-3 fatty acids (20% of energy plus 3% as n-3 fatty acids)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Thr54 allele carriers
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ala54 allele carriers
Number of subjects: 16
Study: 19274788

Group type: EXPERIMENTAL
Intervention: Rice-ORS
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Intravenous fluid
Number of subjects: 175

Group type: COMPARATOR
Intervention: All ORSs
Number of subjects: 175
Study: 17206426

Group type: EXPERIMENTAL
Intervention: Low-dose multidetector computed tomography (MDCT) screening for lung cancer
Number of subjects: 1929
Study: 15266172

Group type: EXPERIMENTAL
Intervention: 99mTc depreotide scan
Number of subjects: 12

Group type: COMPARATOR
Intervention: 99mTc-MDP bone scintigraphy
Number of subjects: 12
Study: 11339397

Group type: EXPERIMENTAL
Intervention: Upper pole placement (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Renal pelvis placement (Group B)
Number of subjects: 40
Study: 9155961

Group type: EXPERIMENTAL
Intervention: Fluconazole 150 mg once weekly for 4-6 weeks
Number of subjects: 230

Group type: COMPARATOR
Intervention: Griseofulvin 500 mg once daily for 4-6 weeks
Number of subjects: 230
Study: 7952982

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Applied relaxation
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Imipramine (mean 233 mg/day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 64
Study: 3417989

Group type: EXPERIMENTAL
Intervention: Carbon monoxide exposure (mean postexposure carboxyhemoglobin 5.9 +/- 0.1%)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Air exposure (mean postexposure carboxyhemoglobin 1.6 +/- 0.1%)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Carbon monoxide exposure
Number of subjects: 30

Group type: COMPARATOR
Intervention: Air exposure
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both exposures
Number of subjects: 30
Study: 31101138

Group type: EXPERIMENTAL
Intervention: Auditory N-back task (NBT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no NBT)
Number of subjects: 39
Study: 29198188

Group type: EXPERIMENTAL
Intervention: 800 g milk
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 800 g yogurt
Number of subjects: 14
Study: 26317357

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (Group D) with rocuronium infusion, maintaining a post-tetanic count of 1-2.
Number of subjects: 67

Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (Group M) with atracurium infusion, maintaining a train of four count of 1-2.
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Overall surgical condition grade in Group D.
Number of subjects: 67

Group type: COMPARATOR
Intervention: Overall surgical condition grade in Group M.
Number of subjects: 67
Study: 23683794

Group type: EXPERIMENTAL
Intervention: Illicit use of prescription stimulants (IUPS)
Number of subjects: 520
Study: 21318438

Group type: EXPERIMENTAL
Intervention: Social integration (measured by AVSI) in former ICU patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: General reference group (n = 6,093)
Number of subjects: 0
Study: 18446582

Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy (NIRS) during reading aloud
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (5 min of resting with eyes closed)
Number of subjects: 0
Study: 17381575

Group type: EXPERIMENTAL
Intervention: Single use intubating laryngeal mask airway (Group S)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Reusable intubating laryngeal mask airway (Group C)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups (Group S and Group C)
Number of subjects: 84
Study: 14764813

Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Serum from GH-treated healthy subjects
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 11157651

Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (INR 2.0 to 3.0)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (INR 2.5 to 3.5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin in addition to oral anticoagulants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (INR 2.0 to 2.3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dipyridamole plus aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low doses of aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caged ball or caged disk valves (INR 3.0-4.5)
Number of subjects: 0
Study: 9137023

Group type: EXPERIMENTAL
Intervention: Dorsal penile nerve block (DPNB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Unanesthetized
Number of subjects: 30
Study: 7956473

Group type: EXPERIMENTAL
Intervention: Normative context
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perceptual context
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional context
Number of subjects: 0
Study: 3612778

Group type: EXPERIMENTAL
Intervention: Behavior modification
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive modification
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior modification
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31856335

Group type: EXPERIMENTAL
Intervention: ToyBox intervention (adapted for Scotland), delivered over 18 weeks, targeting energy balance-related behaviours through teacher-led activities and parental education materials.
Number of subjects: 0
Study: 30295319

Group type: EXPERIMENTAL
Intervention: Family Focused Intervention
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control
Number of subjects: 93
Study: 28603114

Group type: EXPERIMENTAL
Intervention: 4.5mg of oral dexamethasone once a day for 3 days (study group)
Number of subjects: 162

Group type: COMPARATOR
Intervention: 8mg of dexamethasone twice a day for 3 days (control group)
Number of subjects: 162
Study: 26100690

Group type: EXPERIMENTAL
Intervention: Epidural catheter placement
Number of subjects: 330

Group type: COMPARATOR
Intervention: Patient controlled analgesia (PCA)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Intervention Study (IS) group
Number of subjects: 330

Group type: COMPARATOR
Intervention: Observational Study (OS) group
Number of subjects: 330
Study: 24316430

Group type: EXPERIMENTAL
Intervention: Glycosylated 1,25(OH)2D3, single oral dose, up to 40-fold the recommended daily dose (0.5μg/subject/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Synthetic 1,25(OH)2D3 (historically established pharmacokinetics)
Number of subjects: 16
Study: 21878166

Group type: COMPARATOR
Intervention: Shock group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Drainage group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Transfusion group
Number of subjects: 24
Study: 19398065

Group type: EXPERIMENTAL
Intervention: Chiljehyangbuhwan
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 17719323

Group type: EXPERIMENTAL
Intervention: Direct stenting
Number of subjects: 217

Group type: COMPARATOR
Intervention: Stenting after balloon predilation
Number of subjects: 217